Perrigo EBITDA Margin 2010-2025 | PRGO
Perrigo EBITDA Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
2025-03-31 | $4.34B | $0.55B | 12.68% |
2024-12-31 | $4.37B | $0.45B | 10.24% |
2024-09-30 | $4.39B | $0.32B | 7.22% |
2024-06-30 | $4.43B | $0.31B | 6.95% |
2024-03-31 | $4.56B | $0.40B | 8.85% |
2023-12-31 | $4.66B | $0.51B | 11.04% |
2023-09-30 | $4.65B | $0.57B | 12.31% |
2023-06-30 | $4.63B | $0.54B | 11.71% |
2023-03-31 | $4.56B | $0.46B | 10.18% |
2022-12-31 | $4.45B | $0.42B | 9.37% |
2022-09-30 | $4.40B | $0.41B | 9.22% |
2022-06-30 | $4.35B | $0.79B | 18.25% |
2022-03-31 | $4.20B | $0.67B | 15.89% |
2021-12-31 | $4.14B | $0.72B | 17.35% |
2021-09-30 | $4.09B | $0.74B | 18.01% |
2021-06-30 | $4.05B | $0.40B | 9.91% |
2021-03-31 | $4.02B | $0.61B | 15.19% |
2020-12-31 | $4.09B | $0.65B | 15.85% |
2020-09-30 | $3.39B | $0.58B | 16.99% |
2020-06-30 | $3.58B | $0.56B | 15.57% |
2020-03-31 | $3.78B | $0.55B | 14.53% |
2019-12-31 | $3.87B | $0.57B | 14.65% |
2019-09-30 | $4.71B | $0.71B | 15.01% |
2019-06-30 | $4.65B | $0.53B | 11.46% |
2019-03-31 | $4.69B | $0.59B | 12.48% |
2018-12-31 | $4.73B | $0.65B | 13.78% |
2018-09-30 | $4.82B | $0.71B | 14.80% |
2018-06-30 | $4.92B | $1.00B | 20.32% |
2018-03-31 | $4.97B | $1.05B | 21.19% |
2017-12-31 | $4.95B | $1.02B | 20.64% |
2017-09-30 | $4.99B | $0.39B | 7.79% |
2017-06-30 | $5.03B | $-1.24B | -24.70% |
2017-03-31 | $5.13B | $-1.21B | -23.54% |
2016-12-31 | $5.28B | $-1.57B | -29.69% |
2016-09-30 | $2.93B | $-1.68B | -57.33% |
2016-06-30 | $2.94B | $-0.04B | -1.50% |
2015-12-31 | $1.22B | $0.04B | 3.53% |
2015-09-30 | $3.31B | $1.72B | 51.87% |
2014-12-31 | $3.03B | $1.68B | 55.38% |
2014-09-30 | $2.94B | $1.52B | 51.79% |
2013-12-31 | $2.83B | $1.51B | 53.43% |
2013-09-30 | $2.74B | $1.39B | 50.84% |
2012-12-31 | $2.43B | $1.33B | 54.50% |
2012-09-30 | $2.39B | $1.28B | 53.48% |
2011-12-31 | $2.26B | $1.17B | 51.97% |
2011-09-30 | $2.14B | $1.05B | 48.95% |
2010-12-31 | $1.90B | $1.00B | 52.56% |
2010-09-30 | $1.76B | $0.85B | 48.44% |
2009-12-31 | $1.62B | $0.81B | 50.06% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $3.730B | $4.373B |
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $231.137B | 27.79 |
Boston Scientific (BSX) | United States | $154.602B | 38.70 |
Stryker (SYK) | United States | $145.939B | 30.51 |
EssilorLuxottica (ESLOY) | France | $128.884B | 0.00 |
Medtronic (MDT) | Ireland | $105.694B | 14.98 |
Haleon (HLN) | United Kingdom | $51.038B | 29.05 |
Lonza Group Ag (LZAGY) | Switzerland | $49.182B | 0.00 |
ResMed (RMD) | United States | $35.941B | 27.00 |
GE HealthCare Technologies (GEHC) | United States | $32.753B | 15.55 |
Agilent Technologies (A) | United States | $32.296B | 20.98 |
Terumo (TRUMY) | Japan | $27.790B | 36.10 |
Insulet (PODD) | United States | $22.791B | 89.46 |
Koninklijke Philips (PHG) | Netherlands | $21.581B | 15.51 |
Zimmer Biomet Holdings (ZBH) | United States | $18.467B | 11.86 |
Baxter (BAX) | United States | $15.754B | 11.76 |
Smith & Nephew SNATS (SNN) | United Kingdom | $12.622B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
Demant (WILYY) | Denmark | $8.637B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.194B | 21.55 |
Lantheus Holdings (LNTH) | United States | $5.225B | 13.18 |
Prestige Consumer Healthcare (PBH) | United States | $4.175B | 18.65 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
ICU Medical (ICUI) | United States | $3.309B | 24.40 |
Haemonetics (HAE) | United States | $3.259B | 14.85 |
Envista Holdings (NVST) | United States | $3.129B | 26.00 |
GN Store Nord (GNNDY) | Denmark | $2.215B | 18.35 |
QuidelOrtho (QDEL) | United States | $2.080B | 14.30 |
LeMaitre Vascular (LMAT) | United States | $1.832B | 40.94 |
AtriCure (ATRC) | United States | $1.687B | 0.00 |
Neogen (NEOG) | United States | $1.348B | 17.25 |
Acuren (TIC) | United States | $1.300B | 0.00 |
AdaptHealth (AHCO) | United States | $1.212B | 12.30 |
Kestra Medical Technologies (KMTS) | United States | $1.165B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
BioLife Solutions (BLFS) | United States | $1.060B | 0.00 |
Phibro Animal Health (PAHC) | United States | $1.000B | 12.78 |
InMode (INMD) | Israel | $0.922B | 9.29 |
CeriBell (CBLL) | United States | $0.615B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.604B | 0.00 |
Evolus (EOLS) | United States | $0.602B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.582B | 0.00 |
Valneva SE (VALN) | France | $0.535B | 0.00 |
Owens & Minor (OMI) | United States | $0.502B | 4.17 |
Tilray Brands (TLRY) | Canada | $0.468B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.461B | 0.00 |
Surmodics (SRDX) | United States | $0.422B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
SNDL (SNDL) | Canada | $0.342B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.333B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.325B | 11.94 |
Canopy Growth (CGC) | Canada | $0.314B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.310B | 55.20 |
Sanara MedTech (SMTI) | United States | $0.261B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.260B | 21.90 |
ZimVie (ZIMV) | United States | $0.250B | 11.35 |
Sanuwave Health (SNWV) | United States | $0.241B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.237B | 0.00 |
Cerus (CERS) | United States | $0.235B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.212B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.207B | 0.00 |
Quanterix (QTRX) | United States | $0.203B | 0.00 |
Brainsway (BWAY) | Israel | $0.197B | 52.15 |
Biote (BTMD) | United States | $0.197B | 5.53 |
Omeros (OMER) | United States | $0.195B | 0.00 |
Organigram Global (OGI) | Canada | $0.185B | 0.00 |
High Tide (HITI) | Canada | $0.177B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.177B | 14.44 |
Exagen (XGN) | United States | $0.149B | 0.00 |
FitLife Brands (FTLF) | United States | $0.142B | 17.46 |
Jin Medical (ZJYL) | China | $0.119B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
Fonar (FONR) | United States | $0.089B | 11.52 |
MacroGenics (MGNX) | United States | $0.088B | 0.00 |
Agape ATP (ATPC) | $0.088B | 0.00 | |
Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
Veru (VERU) | United States | $0.075B | 0.00 |
InterCure (INCR) | Israel | $0.072B | 0.00 |
Zynex (ZYXI) | United States | $0.072B | 0.00 |
Apyx Medical (APYX) | United States | $0.060B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.058B | 0.00 |
ImmuCell (ICCC) | United States | $0.057B | 0.00 |
United Health Products (UEEC) | United States | $0.054B | 0.00 |
Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
Modular Medical (MODD) | United States | $0.048B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 13.19 |
Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
Nephros (NEPH) | United States | $0.028B | 37.57 |
Safety Shot (SHOT) | United States | $0.021B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
INLIF (INLF) | $0.017B | 0.00 | |
Flora Growth (FLGC) | United States | $0.015B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
Senestech (SNES) | United States | $0.005B | 0.00 |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |